POEM for achalasia has been established as a safe and effective treatment modality, but what about in non-achalasia disorders?
Check out our review covering this!
https://t.co/KjtS8PqYke
@gastrowala @WUGastro
📣@AGA_TIGE WEEKLY HIGHLIGHT📣
📰 @ArvindRenga & @gastrowala review the role of POEM in achalasia and non-achalasia esophageal motility disorders.
#WritingPoetry @WUGastro & @NM_IntEndo
🔎For more details: https://t.co/lu3DZV0LF7
We report outcomes of effort to improve acute pancreatitis care in our large @NorthwesternMed healthcare system. In short, despite comprehensive effort, we could only minimally improve adherence to quality metrics. Not easy to move the needle on quality! https://t.co/rbLMDj0gOn
Excited to support superstar former fellow @AlmuhaidbAymen and his great team at KFSH in Riyadh for this hybrid in-person and virtual endoscopy course in conjunction with @NMGastro. Still time to register for this Dec 7-8 course. https://t.co/JNyVE2L6v0
Honored to be a part of the world wide debut of the newest Endoflip technology which we use to determine myotomy efficacy in POEM. Come to Chicago Live 1 week from today to see a live demonstration during POEM and other excellent cases! @NMGastro
https://t.co/P6tALpOnZ5
Congrats to superstar @NMGastro interventional endoscopy fellow (& former GI fellow) @JonXiaMD on groundbreaking research published on the development of an engineered probiotic to detect IBD. We (@gastrowala, @Scopesdoc, @JRassiwala & I) are very proud! https://t.co/zsVo8OCNNS
Great day @ForegutSociety meeting. Getting to hand out with past president @PJKahrilas is a huge plus. Great sessions today enjoyed the esophageal cancer session #AFS2023@NMGastro
How do you manage a scarred polyp recurrence? Come see practical cases like these (FTRD) at Chicago Live 2023, October 27 @LHChicago. Join a star studded faculty for an endoscopy immersion second to none!@ASGEendoscopy @AmerGastroAssn@AmCollegeGastro
https://t.co/SW6sTTgY2y
Chicago Live 2023 is around the corner! Jasmine Sinha, MD (@JRassiwala) gives us an inside scoop on what’s on the agenda for the conference. Watch now and register for Chicago Live 2023 here:
https://t.co/M8Fnrya8t4
25 mm Paris O-IIa LST piecemeal EMR w/ deep mural injury. How would you classify the DMI? After closure+abx, d/c or admit? Join @Scopesdoc, @JRassiwala & @gastrowala & I at Chicago Live where Doug Rex and others will discuss approach to complex colon EMR. https://t.co/W5CAs0IRjV
Is EUS-BD your choice for this EUS after failed ERCP? I felt dilated GB was always in way. Chose EUS-GBD as safer option (tumor below cystic duct). WWYD? Join us for similar debates at Chicago Live w/ @Scopesdoc, @jrassiwala, @gastrowala+invited faculty! https://t.co/W5CAs0IRjV
Join us August 22, in Oak Brook, IL, to discuss the future of AI in gastroenterology over a peer dinner. Raj Keswani, M.D., M.S. will lead the discussion on adoption challenges, society guidance, and research findings.
Register here: https://t.co/RFs6Ny6TCK
#AIinGI#GITwitter
Join Rajesh N. Keswani, MD, MS, and Lidia Spaho, MD, for another installment of our Dinner With an Expert series on August 16 at 6 pm. Learn more and register:
https://t.co/zUTBy4Tfr3
Coming up at 5:47 pm today, Srinadh Komanduri, MD (@Scopesdoc), joins @LisaDentSpeaks to discuss preventive screenings for colon cancer. Tune in here: https://t.co/uSGVC2erEq
Exciting paper by our Interventional GI fellow @JonXiaMD on the next gen of IBD surveillance with calprotectin sensing probiotics for continuous gut inflammation monitoring! @NMGastro@CrohnsColitisFn
A probiotic engineered to detect a biomarker for active inflammatory bowel disease has promise as a noninvasive disease monitor. Green fluorescent protein activates as the probiotic passes through the gut and can be picked up in stool. In PNAS: https://t.co/BQL7dMftgF